Carole Devaux

Latest publications

Malnutrition, Growth Response and Metabolic Changes Within the First 24 Months After ART Initiation in HIV-infected Children Treated Before the Age of 2 Years in West Africa.

  • HIV Clinical and Translational Research
August 01, 2018
2018 Aug. Pediatr Infect Dis J.37(8):781-787.
By:
  • Jesson J
  • Dahourou DL
  • Amorissani Folquet M
  • Malateste K
  • Yonaba C
  • N'Gbeche MS
  • Ouedraogo S
  • Mea-Assande V
  • Amani-Bosse C
  • Blanche S
  • Timite-Konan M
  • Leroy V
  • Monod Anrs 12206 Study Group (Arendt V DCaSJacftp.

Development of Mimokines, chemokine N terminus-based CXCR4 inhibitors optimized by phage display and rational design.

  • Immuno-Pharmacology and Interactomics
  • HIV Clinical and Translational Research
August 01, 2018
2018 Aug. J Leukoc Biol.104(2):343-357. Epub 2018 Mar 23.
By:
  • Fievez V
  • Szpakowska M
  • Mosbah A
  • Arumugam K
  • Mathu J
  • Counson M
  • Beaupain N
  • Seguin-Devaux C
  • Deroo S
  • Baudy-Floc'h M
  • Chevigne A.

The need for a European hepatitis C programme monitoring resistance to direct-acting antiviral agents in real life to eliminate hepatitis C.

  • HIV Clinical and Translational Research
July 01, 2018
2018 Jul. J Virus Erad.4(3):179-181.
By:
  • Popping S
  • Cento V
  • Garcia F
  • Ceccherini-Silberstein F
  • Seguin-Devaux C
  • Vijver DA
  • Boucher CA
  • on behalf of the HEPVIR working group of the European Society for translational Antiviral Research (ESAR).

Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe.

  • HIV Clinical and Translational Research
June 01, 2018
2018 Jun. BMC Infect Dis.18(1):251.
By:
  • Colagrossi L
  • Hermans LE
  • Salpini R
  • Di Carlo D
  • Pas SD
  • Alvarez M
  • Ben-Ari Z
  • Boland G
  • Bruzzone B
  • Coppola N
  • Seguin-Devaux C
  • Dyda T
  • Garcia F
  • Kaiser R
  • Kose S
  • Krarup H
  • Lazarevic I
  • Lunar MM
  • Maylin S
  • Micheli V
  • Mor O
  • Paraschiv S
  • Paraskevis D
  • Poljak M
  • Puchhammer-Stockl E
  • Simon F
  • Stanojevic M
  • Stene-Johansen K
  • Tihic N
  • Trimoulet P
  • Verheyen J
  • Vince A
  • Lepej SZ
  • Weis N
  • Yalcinkaya T
  • Boucher CAB
  • Wensing AMJ
  • Perno CF
  • Svicher V
  • Hepvir working group of the European Society for translational antiviral research.

Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study.

  • HIV Clinical and Translational Research
June 01, 2018
2018 Jun. Lancet Gastroenterol Hepatol.3(6):383-403. Epub 2018 Mar 27.
By:
  • The Polaris Observatory Collaborators (Devaux C as collaborator for Luxembourg).

Impact of UGT1A1 polymorphisms on Raltegravir and its glucuronide plasma concentrations in a cohort of HIV-1 infected patients.

  • HIV Clinical and Translational Research
May 09, 2018
2018 May. Sci Rep.8(1):7359.
By:
  • Belkhir L
  • Seguin-Devaux C
  • Elens L
  • Pauly C
  • Gengler N
  • Schneider S
  • Ruelle J
  • Haufroid V
  • Vandercam B.

De l’idée de recherche à la conception d’un traitement: Le LIH développe des molécules qui boostent la défense immunitaire contre le cancer.

  • HIV Clinical and Translational Research
May 01, 2018
2018 May. Semper Luxembourg.(102):17-18.
By:
  • Devaux C.

Santé publique au Grand-Duché: naissance de la Luxembourg Public Health Association.

  • Epidemiology and Public Health Scientific Team
  • HIV Clinical and Translational Research
March 01, 2018
2018 Mar. Semper Luxembourg.(100):8-9.
By:
  • Chioti A
  • Fond Harmant L
  • Bohn T
  • Devaux C
  • De Rekeneire N
  • Muller A
  • Schmit JC.

Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe.

  • HIV Clinical and Translational Research
February 01, 2018
2018 Feb. Lancet Gastroenterol Hepatol.3(2):125-133. Epub 2017 Oct 3.
By:
  • Marshall AD
  • Cunningham EB
  • Nielsen S
  • Aghemo A
  • Alho H
  • Backmund M
  • Bruggmann P
  • Dalgard O
  • Seguin-Devaux C
  • Flisiak R
  • Foster GR
  • Gheorghe L
  • Goldberg D
  • Goulis I
  • Hickman M
  • Hoffmann P
  • Jancoriene L
  • Jarcuska P
  • Kaberg M
  • Kostrikis LG
  • Makara M
  • Maimets M
  • Marinho RT
  • Maticic M
  • Norris S
  • Olafsson S
  • Ovrehus A
  • Pawlotsky JM
  • Pocock J
  • Robaeys G
  • Roncero C
  • Simonova M
  • Sperl J
  • Tait M
  • Tolmane I
  • Tomaselli S
  • van der Valk M
  • Vince A
  • Dore GJ
  • Lazarus JV
  • Grebely J
  • International Network on Hepatitis in Substance Users (INHSU).

HIV-1 Infection in Cyprus, the Eastern Mediterranean European Frontier: A Densely Sampled Transmission Dynamics Analysis from 1986 to 2012.

  • HIV Clinical and Translational Research
January 26, 2018
2018 Jan. Sci Rep.8(1):1702.
By:
  • Pineda-Pena AC
  • Theys K
  • Stylianou DC
  • Demetriades I
  • SPREAD/ESAR Programme (Devaux C as collaborators for Luxembourg)
  • Abecasis AB
  • Kostrikis LG.

Suboptimal cotrimoxazole prophylactic concentrations in HIV-infected children according to the WHO guidelines.

  • HIV Clinical and Translational Research
December 01, 2017
2017 Dec. Br J Clin Pharmacol.83(12):2729-2740. Epub 2017 Sep 20.
By:
  • Pressiat C
  • Mea-Assande V
  • Yonaba C
  • Treluyer JM
  • Dahourou DL
  • Amorissani-Folquet M
  • Blanche S
  • Eboua F
  • Ye D
  • Lui G
  • Malateste K
  • Zheng Y
  • Leroy V
  • Hirt D
  • MONOD Study Group (Arendt V DCaSJacftp.

Pharmacokinetics of Efavirenz at a high dose of 25 milligrams per kilogram per day in children 2 to 3 years old.

  • HIV Clinical and Translational Research
July 01, 2017
2017 Jul. Antimicrob Agents Chemother.61(7):e00297-17.
By:
  • Pressiat C
  • Amorissani-Folquet M
  • Yonaba C
  • Treluyer JM
  • Dahourou DL
  • Eboua F
  • Blanche S
  • Mea-Assande V
  • Bouazza N
  • Foissac F
  • Malateste K
  • Ouedraogo S
  • Lui G
  • Leroy V
  • Hirt D
  • MONOD Study Group (Devaux C as collaborator for this project).

Human CD56dimCD16dim cells as an individualized Natural Killer cell subset.

  • HIV Clinical and Translational Research
  • Innate Cellular Immunity and Chronic Inflammation
  • Competence Center for Methodology and Statistics
  • Tumor Microenvironment
June 19, 2017
2017 Jun. Front Immunol.8:699.
By:
  • Amand M
  • Iserentant G
  • Poli A
  • Sleiman M
  • Fievez V
  • Sanchez IP
  • Sauvageot N
  • Michel T
  • Aouali N
  • Janji B
  • Trujillo-Vargas CM
  • Seguin-Devaux C
  • Zimmer J.

Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d'Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort.

  • HIV Clinical and Translational Research
April 25, 2017
2017 Apr. J Int AIDS Soc.20(1):21362.
By:
  • Amani-Bosse C
  • Dahourou DL
  • Malateste K
  • Amorissani-Folquet M
  • Coulibaly M
  • Dattez S
  • Emieme A
  • Barry M
  • Rouzioux C
  • N'Gbeche S
  • Yonaba C
  • Timite-Konan M
  • Mea V
  • Ouedraogo S
  • Blanche S
  • Meda N
  • Seguin-Devaux C
  • Leroy V.

Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Cote d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial.

  • HIV Clinical and Translational Research
April 24, 2017
2017 Apr. BMC Med.15(1):85.
By:
  • Dahourou DL
  • Amorissani-Folquet M
  • Malateste K
  • Amani-Bosse C
  • Coulibaly M
  • Seguin-Devaux C
  • Toni T
  • Ouedraogo R
  • Blanche S
  • Yonaba C
  • Eboua F
  • Lepage P
  • Avit D
  • Ouedraogo S
  • Van de Perre P
  • N'Gbeche S
  • Kalmogho A
  • Salamon R
  • Meda N
  • Timite-Konan M
  • Leroy V
  • MONOD Study Group.

Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study.

  • HIV Clinical and Translational Research
March 17, 2017
2017 Mar. Lancet Gastroenterol Hepatol.2(5):325-336. Epub 2017 Mar 15.
By:
  • The European Union HCV Collaborators (Seguin-Devaux C as collaborator for Luxembourg).

Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.

  • HIV Clinical and Translational Research
March 01, 2017
2017 Mar. Lancet Gastroenterol Hepatol.2(3):161–176. Epub 2016 Dec 15.
By:
  • The Polaris Observatory HCV Collaborators (Arendt V Seguin-Devaux C and Struck D for Luxembourg)
  • .

The envelope cytoplasmic tail of HIV-1 Subtype C contributes to poor replication capacity through low viral infectivity and cell-to-cell transmission.

  • Immuno-Pharmacology and Interactomics
  • Innate Cellular Immunity and Chronic Inflammation
  • HIV Clinical and Translational Research
September 06, 2016
2016 Sep. PLoS One.11(9):e0161596.
By:
  • Santos da Silva E
  • Mulinge M
  • Lemaire M
  • Masquelier C
  • Beraud C
  • Rybicki A
  • Servais JY
  • Iserentant G
  • Schmit JC
  • Seguin-Devaux C
  • Perez Bercoff D.

New findings in HCV genotype distribution in selected West European, Russian and Israeli regions.

  • HIV Clinical and Translational Research
August 01, 2016
2016 Aug. J Clin Virol.81:82-9. Epub 2016 May 24.
By:
  • Kartashev V
  • Doring M
  • Nieto L
  • Coletta E
  • Kaiser R
  • Sierra S
  • HCV EuResist Study group (Devaux C for Luxembourg).

Improved sensitivity of a dual-target HIV-1 Qualitative Test for plasma and dried blood spots.

  • HIV Clinical and Translational Research
July 01, 2016
2016 Jul. J Clin Microbiol.54(7):1877-82. Epub 2016 May 18.
By:
  • Templer SP
  • Seiverth B
  • Baum P
  • Stevens W
  • Seguin-Devaux C
  • Carmona S.